Annexon Inc logo

ANNX - Annexon Inc Share Price

$21.48 -0.4  -1.6%

Last Trade - 8:20pm

Market Cap £599.5m
Enterprise Value £574.1m
Revenue £n/a
Position in Universe 2541st / 6368
Unlock ANNX Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -2.41%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Annexon Inc revenues was not reported. Net loss applicable to common stockholders increased 42% to $12.6M. Higher net loss reflects Research and development increase from $3.6M to $7.7M (expense), Compensation and personnel-related increase from $1M to $2.2M (expense), General and administrative increase from $319K to $964K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ANNX Revenue Unlock ANNX Revenue

Net Income

ANNX Net Income Unlock ANNX Revenue

Normalised EPS

ANNX Normalised EPS Unlock ANNX Revenue

PE Ratio Range

ANNX PE Ratio Range Unlock ANNX Revenue

Dividend Yield Range

ANNX Dividend Yield Range Unlock ANNX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ANNX EPS Forecasts Unlock ANNX Revenue
Profile Summary

Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology addressing classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Its product candidate, ANX005, is a monoclonal antibody formulated for intravenous administration in autoimmune and neurodegenerative disorders. Its product candidate, ANX007, is an antigen-binding fragment (Fab), formulated for intravitreal administration for the treatment of neurodegenerative ophthalmic disorders. It is also developing ANX009, an investigational, subcutaneous formulation of a Fab designed for the treatment of systemic autoimmune diseases.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated March 3, 2011
No. of Shareholders: n/a
No. of Employees: 30
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 36,008,687
Free Float (0.0%)
Eligible for
ANNX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ANNX
Upcoming Events for ANNX
Frequently Asked Questions for Annexon Inc
What is the Annexon Inc share price?

As of 8:20pm, shares in Annexon Inc are trading at $21.48, giving the company a market capitalisation of £599.5m. This share price information is delayed by 15 minutes.

How has the Annexon Inc share price performed this year?

Shares in Annexon Inc are currently trading at $21.48 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Annexon Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Annexon Inc?

There are no analysts currently covering Annexon Inc.

When will Annexon Inc next release its financial results?

Annexon Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Annexon Inc dividend yield?

Annexon Inc does not currently pay a dividend.

Does Annexon Inc pay a dividend?

Annexon Inc does not currently pay a dividend.

When does Annexon Inc next pay dividends?

Annexon Inc does not currently pay a dividend.

How do I buy Annexon Inc shares?

To buy shares in Annexon Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Annexon Inc?

Shares in Annexon Inc are currently trading at $21.48, giving the company a market capitalisation of £599.5m.

Where are Annexon Inc shares listed? Where are Annexon Inc shares listed?

Here are the trading details for Annexon Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ANNX
What kind of share is Annexon Inc?

Based on an overall assessment of its quality, value and momentum, Annexon Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Annexon Inc share price forecast 2020?

We were not able to load any forecast data for Annexon Inc.

How can I tell whether the Annexon Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Annexon Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $21.48, shares in Annexon Inc are trading at 15.87% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Annexon Inc PE Ratio?

We were not able to find PE ratio data for Annexon Inc.

Who are the key directors of Annexon Inc?

We were unable to find the directors for Annexon Inc.

Who are the major shareholders of Annexon Inc?

Here are the top five shareholders of Annexon Inc based on the size of their shareholding:

Deerfield Management Company, L.P. Hedge Fund
Percentage owned: 4.49% (1.62m shares)
Lew (Jennifer) Individual Investor
Percentage owned: 0.01% (2.00k shares)
Similar to ANNX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.